Pharmaceutical giant Eli Lilly ( LLY -0.35%) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster ...
Corvus Pharmaceuticals said it would announce interim data from a Phase 1 clinical trial of its treatment for moderate to severe eczema. The clinical-stage biopharmaceutical company said it will ...
Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, today announced that Health Canada approved XEOMIN® (incobotulinumtoxinA) for the treatment of post-stroke lower ...